CL Verweij

1.7k total citations
26 papers, 1.4k citations indexed

About

CL Verweij is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, CL Verweij has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Rheumatology and 7 papers in Hematology. Recurrent topics in CL Verweij's work include Rheumatoid Arthritis Research and Therapies (7 papers), Platelet Disorders and Treatments (5 papers) and Complement system in diseases (5 papers). CL Verweij is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Platelet Disorders and Treatments (5 papers) and Complement system in diseases (5 papers). CL Verweij collaborates with scholars based in Netherlands, France and United Kingdom. CL Verweij's co-authors include FC Breedveld, Eric L. Kaijzel, JJ Sixma, JP Girma, Saskia le Cessie, B. A. C. Dijkmans, Hans Pannekoek, Dominique Meyer, A Bakker and Dominique Meyer and has published in prestigious journals such as Nucleic Acids Research, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

CL Verweij

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CL Verweij Netherlands 14 507 401 226 191 171 26 1.4k
Irene J. Check United States 22 515 1.0× 231 0.6× 167 0.7× 105 0.5× 242 1.4× 55 1.5k
Henny G. Otten Netherlands 24 749 1.5× 250 0.6× 271 1.2× 132 0.7× 293 1.7× 118 2.1k
Carole C. Kurman United States 15 1.1k 2.1× 149 0.4× 170 0.8× 210 1.1× 249 1.5× 29 1.9k
Armead H. Johnson United States 20 830 1.6× 294 0.7× 280 1.2× 141 0.7× 168 1.0× 43 1.6k
E R de Groot Netherlands 15 945 1.9× 239 0.6× 166 0.7× 243 1.3× 291 1.7× 17 1.7k
Myoung Hee Park South Korea 21 452 0.9× 173 0.4× 157 0.7× 87 0.5× 161 0.9× 83 1.2k
Bernard Boutin France 12 738 1.5× 118 0.3× 159 0.7× 150 0.8× 175 1.0× 21 1.5k
Leonard Ellman United States 24 711 1.4× 525 1.3× 303 1.3× 122 0.6× 299 1.7× 61 1.8k
Max Hamburger United States 15 501 1.0× 211 0.5× 504 2.2× 113 0.6× 189 1.1× 26 1.4k
P M Lydyard United Kingdom 20 1000 2.0× 173 0.4× 205 0.9× 118 0.6× 300 1.8× 49 1.6k

Countries citing papers authored by CL Verweij

Since Specialization
Citations

This map shows the geographic impact of CL Verweij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CL Verweij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CL Verweij more than expected).

Fields of papers citing papers by CL Verweij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CL Verweij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CL Verweij. The network helps show where CL Verweij may publish in the future.

Co-authorship network of co-authors of CL Verweij

This figure shows the co-authorship network connecting the top 25 collaborators of CL Verweij. A scholar is included among the top collaborators of CL Verweij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CL Verweij. CL Verweij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vosslamber, Saskia, Carina L. Bos, Joyce Lübbers, et al.. (2014). A1.77 Interferon regulatory factor 5 (IRF5) gene variant RS2004640 is associated with carotid intima media thickness in rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 73. A34–A34. 3 indexed citations
2.
Thurlings, Rogier M., Maria J H Boumans, Janneke Tekstra, et al.. (2010). The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis. Annals of the Rheumatic Diseases. 69. A14–A15. 11 indexed citations
3.
4.
5.
Aken, Jill van, T. Huizinga, FC Breedveld, et al.. (2004). Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis. Arthritis Research. 6(Suppl 1). 34–34. 8 indexed citations
6.
Kaijzel, Eric L., Pieter van de Linde, A Bakker, et al.. (2001). Allele-specific quantification of tumor necrosis factor α (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes and Immunity. 2(3). 135–144. 81 indexed citations
7.
Esch, Wim J.E. van, Carelle C. Reparon‐Schuijt, E. W. Nivine Levarht, et al.. (2001). Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells. Clinical & Experimental Immunology. 123(3). 496–504. 12 indexed citations
8.
Huizinga, T., Eric L. Kaijzel, Eric Zanelli, et al.. (1999). Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis. Genes and Immunity. 1(2). 91–96. 58 indexed citations
9.
Veen, Anneke van, et al.. (1999). An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes and Immunity. 1(1). 61–65. 221 indexed citations
10.
Dijkmans, B. A. C., et al.. (1997). Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.. PubMed. 24(1). 55–60. 222 indexed citations
11.
Kaijzel, Eric L., et al.. (1997). Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation.. PubMed. 46(1). 32–41. 255 indexed citations
12.
Verweij, CL, et al.. (1996). Alternative splicing of IgA Fc receptor (CD89) transcripts. Gene. 175(1-2). 279–280. 11 indexed citations
13.
Derkx, H. H. F., Karlien F. Bruin, C. Victor Jongeneel, et al.. (1995). Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro; relationship to TNF gene polymorphism. Journal of Endotoxin Research. 2(1). 19–25. 20 indexed citations
14.
15.
Bahnak, Bruce R., J. M. Lavergne, CL Verweij, et al.. (1988). Carrier Detection in Severe (Type III) von Willebrand Disease Using Two Intragenic Restriction Fragment Length Polymorphisms. Thrombosis and Haemostasis. 60(2). 178–181. 25 indexed citations
16.
Girma, JP, et al.. (1987). Structure-function relationship of human von Willebrand factor. Blood. 70(3). 605–611. 118 indexed citations
17.
Lavergne, J. M., Bruce R. Bahnak, CL Verweij, Hans Pannekoek, & Dominique Meyer. (1987). A second Xba I polymorphic site within the human von Willebrand factor (vWF)gene. Nucleic Acids Research. 15(21). 9099–9099. 13 indexed citations
18.
Pannekoek, Hans, Harry Veerman, Hans Lambers, et al.. (1986). Endothelial plasminogen activator inhibitor: A new member of the serpin gene family. Thrombosis Research. 41. 20–20. 3 indexed citations
19.
Quadt, R., CL Verweij, Carlie J.M. de Vries, E Briët, & Hans Pannekoek. (1986). A polymorphic Xba I site within the human von Willebrand factor (vWF) gene identified by a vWF cDNA clone. Nucleic Acids Research. 14(17). 7139–7139. 22 indexed citations
20.
Verweij, CL, et al.. (1985). RFLP for a human von Willebrand factor (vWF) cDNA clone, pvWF1100. Nucleic Acids Research. 13(22). 8289–8289. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene J. Check Breakdown of academic impact, for papers by Henny G. Otten Breakdown of academic impact, for papers by Carole C. Kurman Breakdown of academic impact, for papers by Armead H. Johnson Breakdown of academic impact, for papers by E R de Groot Breakdown of academic impact, for papers by Myoung Hee Park Breakdown of academic impact, for papers by Bernard Boutin Breakdown of academic impact, for papers by Leonard Ellman Breakdown of academic impact, for papers by Max Hamburger Breakdown of academic impact, for papers by P M Lydyard
Rankless by CCL
2026